PMA · Approved
ApprovedTHERAKOS CELLEX Photopheresis System (CELLEX), THERAKOS CELLEX Photopheresis Procedural Kit (CLXUSA and CLXECP), THERAK
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Therakos Development Limited · LNR System, Photopheresis, Extracorporeal
Approved on Aug 10, 2023 through premarket approval, which rests on the device’s own clinical evidence after a 27-day review.
- Decided
- Aug 10, 2023
- Review
- 27 days
- Class
- Class III
- Product code
- LNR
- Recalls
- None
PMA approvals rest on their own clinical evidence and do not claim a predicate, so this family tree starts here.
Sources: FDA PMA database (decision fields and supplements), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in LNR? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
- Candidate predicates for a device like this, rankedin the report
- Recall history across each candidate’s familyin the report
Does it have a predicate?
PMA decisions do not claim a predicate device.
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
How does its category compare?
All LNR devicesLNR System, Photopheresis, Extracorporeal: FDA decisions, review times, recalls and adverse event reports over 20 years. 2023, this device’s year, is highlighted.
FDA decisions per year · LNR
3in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · LNR
Too few LNR 510(k)s in any year since 2007 to give a median.
Recalls per year · LNR
2in 2021
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · LNR
145in 2025
MAUDE reports naming product code LNR, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 0 | 15 |
| 2008 | 3 | — | 0 | 8 |
| 2009 | 4 | — | 0 | 12 |
| 2010 | 1 | — | 2 | 36 |
| 2011 | 7 | — | 3 | 94 |
| 2012 | 5 | — | 0 | 120 |
| 2013 | 7 | — | 0 | 222 |
| 2014 | 2 | — | 0 | 377 |
| 2015 | 5 | — | 0 | 319 |
| 2016 | 5 | — | 0 | 318 |
| 2017 | 8 | — | 0 | 261 |
| 2018 | 4 | — | 0 | 183 |
| 2019 | 2 | — | 0 | 161 |
| 2020 | 1 | — | 0 | 141 |
| 2021 | 2 | — | 2 | 114 |
| 2022 | 3 | — | 0 | 97 |
| 2023 | 3 | — | 0 | 83 |
| 2024 | 0 | — | 0 | 151 |
| 2025 | 3 | — | 0 | 145 |
| 2026 | 0 | — | 0 | — |
https://510kreport.com/device/P860003/S110 · printed Nov 6, 2026
Cite this page
510(k) Report. “P860003/S110: THERAKOS CELLEX Photopheresis System (CELLEX), THERAKOS CELLEX Photopheresis Procedural Kit (CLXUSA and CLXECP), THERAK.” Lineage record from FDA PMA data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/P860003/S110
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Page last updated Nov 3, 2026